Objectives: Some helminths have been known to have a treatment effect in inflammatory bowel diseases, including Crohn's disease (CD); however, live parasite therapy can cause unwanted side effects. To develop a safe therapeutic, we investigated the preventive or therapeutic potential of proteins from the third stage larva of A. simplex in a mouse model. We also analyzed the cytokine profile from splenic and mesenteric lymph node lymphocytes to elucidate the underlying immunological mechanism. Methods: CD was induced in mice with DSS, and the effect of an A. simplex larval protein on CD was assessed. A change in body weight and DAI (disease activity index) were observed in mice. The expression levels of cytokines from mesenteric lymph nodes (MLN) compared to splenic lymphocytes were measured with ELISA. Results: Peritoneal administration of preventive and therapeutic A. simplex larval proteins attenuated DSS-induced CD by a reduction of the DAI and weight loss. A shortening of colon length was more definitely observed in the therapeutic group than in the preventive group. The cytokine expression levels were more obvious in lymphocytes from mesenteric lymph nodes than from splenic lymphocytes. Conclusions: Taken together, these results suggest that A. simplex proteins can change cytokine profiles and may have a preventive effect in DSS-induced CD mice.
Inflammatory bowel diseases (IBD) such as Crohn's disease (CD) are chronic inflammatory disorders of the intestine. Although the pathogenesis of IBD remains unknown, it is now considered to be a multifactorial disease that involves both genetic and environmental factors. The hygiene hypothesis (Strachan, 1989) contends that infants and children who lack exposure to infectious agents, symbiotic microorganisms, and parasites are more susceptible to allergic diseases by suppressing the natural development of the immune system. 1 The high prevalence of allergic diseases in developed countries compared to less developed countries strongly supports the theory of the "hygiene hypothesis." Improved hygiene has been considered to alter the balance between type a failure of immune regulation resulting in allergymediated Th2 responses. 2 In the absence of Th1- 
MATERIALS AND METHODS

Mice
Eight-week-old female C57BL/6 mice were purchased from Hyochang Science (Daegu, Korea). 
Experimental groups of mice and A. simplex protein injection
We divided the mice into 4 groups, which consisted 
Induction and assessment of DSSinduced colitis
In order to induce intestinal inflammation, mice were given a solution of drinking water containing 3% DSS The colons were removed and measured from 1 cm above the anus to the top of the cecum.
Lymphocyte preparation and cytokine analysis
After the mice were sacrificed, lymphocytes from their spleens and mesenteric lymph nodes (MLN) were isolated to determine the level of specific cytokines.
The spleens and MLN were disrupted and treated with 
Statistical analysis
Experiments were conducted at least in triplicate, and data are expressed as means ± SD. Student's t-test was applied for comparison between groups. P values of < 0.05 were considered statistically significant in Fig. 1 . Changes in body weight in each group of mice. SP + DSS and ES + DSS groups are preventive groups; DSS + SP and DSS + ES groups are therapeutic groups. The average body weight was higher in the preventive groups than in the therapeutic groups. all experiments.
RESULTS
A challenge with Anisakis simplexderived protein can protect mice against DSS-induced colitis
To evaluate the potential effects of A. simplexderived protein, the mice were treated with SP and ES products (10 μg/mouse, once a day) for 7 days before or after DSS administration. A remarkable weight loss of mice after DSS administration was observed. The body weight in the preventive group slowly increased until the 12 th day and decreased after that. This reduction was consistent with the DSS injection. In the therapeutic group, the body weight rapidly fell after DSS administration, but the mice gained weight along with injection of A. simplex protein (Fig. 1) . The average body weight was higher in the preventive group than in the therapeutic group (18.3 g ± 1.22, 18.0 g ± 1.14). The DAI decreased after 14 days in the preventive group, whereas it was sustained in the therapeutic group (Fig. 2) . The colon length of mice in the therapeutic and DSS groups was much shorter than in the preventive and negative control groups (Fig. 3 ). These findings imply that A.
simplex protein injection resulted in a reduction of the DAI and maintenance of body weight and colon length, especially in the preventive group.
Proteins from Anisakis simplex L3 can change the cytokine profile in DSStreated mice
The cytokine expression levels were obvious in lymphocytes from mesenteric lymph nodes compared to splenic lymphocytes (Fig. 4) . The pro-inflammatory cytokines IL-1α and IL-1β were highly increased in the MLN of the DSS-injected mice group. A decrease in IL-1α was evident in the preventive group, while the expression level of IL-1β dropped in both the preventive and therapeutic groups (Fig.   4A, B) . These results indicate that A. simplex-derived protein can suppress the expression of proinflammatory cytokines. In the case of IL-2, the decrease was noticeable in the therapeutic group, particularly by ES product (Fig. 4C) . IFN-γ was nearly unexpressed in the spleen, while the expression of IFN-γ in MLN lymphocytes of the DSS group was significantly increased (Fig. 4D) . colonic tissue and mesenteric lymph nodes. 15 In addition, T. suis egg therapy has already successfully been tried in CD patients. 16 Trichinella spiralis infection brought a similar protective effect in DNBS--induced colitis mice, which was associated with an IFN-γ and IL-12 decrease. 17 These previous studies correspond with our result of a significant reduction of IFN-γ. This finding leads to the conclusion that helminth or helminth-derived proteins could be used in the treatment and prevention of IBD.
In conclusion, A. simplex proteins can exert a treatment effect by decreasing proinflammatory cytokines and can be a candidate for shaping the human immune system. These trials can help us understand the mechanism of CD and provide a new insight for CD control.
